retatrutide trial near me Eli Lilly's Phase 3 clinical studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial weight loss. Read about the work via the link in the comments Retatrutide UK: 2026 Clinical Trial

Diana Mesa, RDN, LDN, CDCES, founder of En La Mesa Nutrition, agrees, adding that Berberine does have some similarities [to GLP-1 RA medications] in that it can trigger the pancreas to release insulin and helps make cells more sensitive to the effect of insulin, which is a characteristic similar to what Metformin [another prescription medication prescribed to treat type 2 diabetes and other off-label conditions] does. Still, she notes that its unclear whether or not Berberine has any appetite-suppressing effects like Ozempic and similar medications

I also love having the option to video visit because I live way out in West TX

Davies MJ, Bergenstal R, Bode B, Kushner RF, Lewin A, Skjoth TV, Andreasen AH, Jensen CB, DeFronzo RA

It is not approved for the treatment of Type 1 diabetes and is not to be started by individuals with current or past pancreatitis

Both medications can be effective for weight loss, but side effects, health conditions, cost, and personal preference often guide which option is the better fit

Although dose changes for warfarin are not typically needed when starting GLP-1 therapy, adjustments may be made based on your INR levels